Originally published on Chacruna.net by Dr. Alli Feduccia

Clinical trials of MDMA, psilocybin, ketamine, and ayahuasca are offering a glimpse that the future may hold psychiatric treatments far different from daily drug prescriptions currently used for anxiety and addictive disorders. Research is only beginning to unravel how these experiences in altered states of consciousness produce large shifts in psychological functioning. Although a purely biochemical model is not inclusive of psycho-spiritual or transpersonal explanations, here I describe what scientific explorations are revealing about how the brain responds when … read full article.

Alli Feduccia, PhD
Alli Feduccia, PhD Administrator
Dr. Alli Feduccia is a Co-Founder of Psychedelic Support and a Neuropharmacologist working as a Clinical Data Scientist at MAPS Public Benefit Corporation in support of the MAPS MDMA trials.

Subscribe to Psychedelic Support

We'll keep you up to date with the latest in Psychedelic Therapy and Research

You have Successfully Subscribed!

Share This

INTEGRATION EVENTS

TRAINING EVENTS

WHO WE ARE
KEEP IN TOUCH